Display options
Cite
Guo J, Xiao F, Ren W, et al. Circular Ribonucleic Acid circFTO Promotes Angiogenesis and Impairs Blood-Retinal Barrier . Front Mol Biosci. 2021;8:685466doi: 10.3389/fmolb.2021.685466.
Guo, J., Xiao, F., Ren, W., Zhu, Y., Du, Q., Li, Q., & Li, X. (2021). Circular Ribonucleic Acid circFTO Promotes Angiogenesis and Impairs Blood-Retinal Barrier . Frontiers in molecular biosciences, 8685466. https://doi.org/10.3389/fmolb.2021.685466
Guo, Jianjin, et al. "Circular Ribonucleic Acid circFTO Promotes Angiogenesis and Impairs Blood-Retinal Barrier ." Frontiers in molecular biosciences vol. 8 (2021): 685466. doi: https://doi.org/10.3389/fmolb.2021.685466
Guo J, Xiao F, Ren W, Zhu Y, Du Q, Li Q, Li X. Circular Ribonucleic Acid circFTO Promotes Angiogenesis and Impairs Blood-Retinal Barrier . Front Mol Biosci. 2021 Aug 04;8:685466. doi: 10.3389/fmolb.2021.685466. eCollection 2021. PMID: 34422901; PMCID: PMC8371555.
Copy Download .nbib Format: NLM
Share it on

Front Mol Biosci. 2021 Aug 04;8:685466. doi: 10.3389/fmolb.2021.685466. eCollection 2021.

Circular Ribonucleic Acid circFTO Promotes Angiogenesis and Impairs Blood-Retinal Barrier .

Frontiers in molecular biosciences

Jianjin Guo, Feng Xiao, Wei Ren, Yikun Zhu, Qiujing Du, Qian Li, Xing Li

Affiliations

  1. Department of Endocrinology and Metabolism, The Second Hospital of Shanxi Medical University, Taiyuan, China.
  2. Department of Oncology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
  3. Department of Endocrinology and Metabolism, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, China.
  4. Shanxi Medical University, Taiyuan, China.
  5. Shanxi Medical University, Jinzhong, China.

PMID: 34422901 PMCID: PMC8371555 DOI: 10.3389/fmolb.2021.685466

[No abstract available.]

Copyright © 2021 Guo, Xiao, Ren, Zhu, Du, Li and Li.

Keywords: MiR-128-3p; TXNIP; circFTO; diabetic retinopathy; molecular biology

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. EBioMedicine. 2019 Nov;49:341-353 - PubMed
  2. Life Sci. 2021 Feb 15;267:118988 - PubMed
  3. Physiol Rev. 2004 Jul;84(3):869-901 - PubMed
  4. Am J Physiol Cell Physiol. 2020 May 1;318(5):C848-C856 - PubMed
  5. J Cell Commun Signal. 2020 Sep;14(3):351-353 - PubMed
  6. Acta Diabetol. 2020 Apr;57(4):479-489 - PubMed
  7. J Clin Invest. 2020 Jul 1;130(7):3833-3847 - PubMed
  8. Cell Tissue Res. 2020 Dec;382(3):477-486 - PubMed
  9. Int J Mol Sci. 2019 Dec 27;21(1): - PubMed
  10. Int J Med Sci. 2019 Mar 10;16(4):513-518 - PubMed
  11. Nat Med. 2013 Sep;19(9):1141-6 - PubMed
  12. Prog Retin Eye Res. 2019 Sep;72:100756 - PubMed
  13. J Ophthalmol. 2011;2011:589813 - PubMed
  14. Nature. 2014 Jan 16;505(7483):344-52 - PubMed
  15. PLoS One. 2015 May 28;10(5):e0128372 - PubMed
  16. JAMA. 2003 Oct 15;290(15):2057-60 - PubMed
  17. Life Sci. 2020 Sep 1;256:117888 - PubMed
  18. Nat Rev Endocrinol. 2021 Apr;17(4):195-206 - PubMed
  19. J Clin Invest. 2011 Jan;121(1):369-83 - PubMed
  20. Gene. 2020 Jul 15;747:144654 - PubMed
  21. Gene. 2020 Jul 15;747:144653 - PubMed
  22. Nucleic Acids Res. 2014 Jan;42(Database issue):D92-7 - PubMed
  23. Circulation. 2017 Oct 24;136(17):1629-1642 - PubMed
  24. Biochem Biophys Res Commun. 2020 Jan 1;521(1):98-105 - PubMed
  25. J Cell Physiol. 2021 Aug;236(8):5848-5864 - PubMed
  26. Cell Metab. 2013 Jan 8;17(1):20-33 - PubMed
  27. Nature. 2013 Mar 21;495(7441):384-8 - PubMed
  28. Open Ophthalmol J. 2013;7:4-10 - PubMed
  29. Mol Cell. 2018 Aug 2;71(3):428-442 - PubMed
  30. Eur J Ophthalmol. 2011;21 Suppl 6:S3-9 - PubMed
  31. Exp Cell Res. 2020 Nov 15;396(2):112293 - PubMed
  32. Front Cell Dev Biol. 2020 Sep 03;8:850 - PubMed
  33. Nat Rev Mol Cell Biol. 2020 Aug;21(8):475-490 - PubMed
  34. Diabetes Care. 2016 Sep;39(9):1643-9 - PubMed
  35. Exp Eye Res. 2016 Aug;149:100-106 - PubMed
  36. Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6082-6090 - PubMed
  37. Invest Ophthalmol Vis Sci. 2009 Feb;50(2):844-50 - PubMed
  38. Lancet. 2010 Jul 10;376(9735):124-36 - PubMed
  39. Physiol Rev. 2013 Jan;93(1):137-88 - PubMed

Publication Types